selected publications
- Use of focal radiotherapy boost for prostate cancer and perceived barriers toward its implementation: a survey. medRxiv : the preprint server for health sciences. 2023 Article GET IT
- Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis. European urology oncology. 2023 Review GET IT
- Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men. Scientific reports. 2023 Academic Article GET IT
- The role of AI in prostate MRI quality and interpretation: Opportunities and challenges. European journal of radiology. 2023 Review GET IT
- Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography. European urology oncology. 2023 Academic Article GET IT
-
Prostate cancer grade migration and facility-level treatment trends for grade group 1 disease.
JNCI cancer spectrum.
2023
Academic Article
GET IT
Times cited: 1 -
MRI-LINAC: A transformative technology in radiation oncology.
Frontiers in oncology.
2023
Review
GET IT
Times cited: 17 -
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Clinical and translational radiation oncology.
2022
Academic Article
GET IT
Times cited: 13 - Response to Takahashi. Journal of the National Cancer Institute. 2022 Comment GET IT
- Pulse Sequence Dependence of a Simple and Interpretable Deep Learning Method for Detection of Clinically Significant Prostate Cancer Using Multiparametric MRI. Academic radiology. 2022 Academic Article GET IT
-
Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology.
Frontiers in oncology.
2022
Review
GET IT
Times cited: 4 -
Corrigendum re "Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?" [Eur Urol Open Sci 2020;22:9-16].
European urology open science.
2022
Article
GET IT
Times cited: 17 -
Grade Migration of Prostate Cancer in the United States During the Last Decade.
Journal of the National Cancer Institute.
2022
Review
GET IT
Times cited: 8 -
Evolving Trends in the Management of Low-Risk Prostate Cancer.
Clinical genitourinary cancer.
2022
Academic Article
GET IT
Times cited: 2 -
Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer.
World journal of urology.
2022
Academic Article
GET IT
Times cited: 2 -
Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy.
Advances in radiation oncology.
2022
Academic Article
GET IT
Times cited: 1 -
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer.
International journal of radiation oncology, biology, physics.
2021
Review
GET IT
Times cited: 1 -
68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study.
Translational oncology.
2021
Academic Article
GET IT
Times cited: 18 -
Prostate SBRT Dose Escalation (9 Gy × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?.
International journal of radiation oncology, biology, physics.
2021
Editorial Article
GET IT
Times cited: 1 - Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation. Clinical and translational radiation oncology. 2021 Review GET IT
-
Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
Journal of applied clinical medical physics.
2021
Academic Article
GET IT
Times cited: 2 -
Deep learning-based synthetic CT generation for MR-only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator.
Journal of applied clinical medical physics.
2021
Academic Article
GET IT
Times cited: 4 - Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolization, a Pilot Study. Journal of vascular and interventional radiology : JVIR. 2021 Letter GET IT
-
Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use.
Annals of surgical oncology.
2021
Academic Article
GET IT
Times cited: 8 -
Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?.
European urology open science.
2020
Review
GET IT
Times cited: 3 -
Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the US.
JAMA network open.
2020
Academic Article
GET IT
Times cited: 9 -
Active Surveillance for Men with Intermediate Risk Prostate Cancer.
The Journal of urology.
2020
Academic Article
GET IT
Times cited: 11 -
Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy.
Nature reviews. Clinical oncology.
2020
Academic Article
GET IT
Times cited: 52 -
Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?.
International journal of radiation oncology, biology, physics.
2020
Editorial Article
GET IT
Times cited: 3 -
Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.
JAMA network open.
2020
Academic Article
GET IT
Times cited: 45 -
Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.
Breast cancer research : BCR.
2018
Academic Article
GET IT
Times cited: 4 -
Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?.
Clinical breast cancer.
2018
Academic Article
GET IT
Times cited: 21 -
The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
Clinical breast cancer.
2017
Academic Article
GET IT
Times cited: 13 -
Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
American journal of clinical oncology.
2017
Academic Article
GET IT
Times cited: 7 -
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.
Transplantation.
2017
Academic Article
GET IT
Times cited: 12 -
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2016
Academic Article
GET IT
Times cited: 47 -
Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
American journal of clinical oncology.
2016
Academic Article
GET IT
Times cited: 13 -
Disease-free survival according to the use of postmastectomy radiation therapy after neoadjuvant chemotherapy.
Clinical breast cancer.
2014
Academic Article
GET IT
Times cited: 11 -
Impact of oncotype DX recurrence score in the management of breast cancer cases.
Clinical breast cancer.
2013
Academic Article
GET IT
Times cited: 17 -
Administration of concurrent vaginal brachytherapy during chemotherapy for treatment of endometrial cancer.
International journal of radiation oncology, biology, physics.
2013
Academic Article
GET IT
Times cited: 7 -
Is there a tradeoff in using modified high tangent field radiation for treating an undissected node-positive axilla?.
Clinical breast cancer.
2013
Academic Article
GET IT
Times cited: 7 -
Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.
International journal of radiation oncology, biology, physics.
2011
Academic Article
GET IT
Times cited: 57 -
Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts.
The Journal of pathology.
2005
Academic Article
GET IT
Times cited: 79